Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Other
Ratios

Vistagen Therapeutics (VTGN) Long-Term Debt Issuances (2020 - 2025)

Vistagen Therapeutics' Long-Term Debt Issuances history spans 5 years, with the latest figure at $1.0 million for Q2 2025.

  • For Q2 2025, Long-Term Debt Issuances changed N/A year-over-year to $1.0 million; the TTM value through Dec 2025 reached $1.0 million, changed N/A, while the annual FY2021 figure was $224400.0, N/A changed from the prior year.
  • Long-Term Debt Issuances for Q2 2025 was $1.0 million at Vistagen Therapeutics, up from $224400.0 in the prior quarter.
  • Across five years, Long-Term Debt Issuances topped out at $1.0 million in Q2 2025 and bottomed at $1.0 million in Q2 2025.